tyrosinase-specific human recombinant T-Cell Receptor-Like antibodies (Adicet)

N/A

Report date: 2025/03/20 14:36:22

Base Information

Drug Nametyrosinase-specific human recombinant T-Cell Receptor-Like antibodies (Adicet)

Drug Alias Nametyrosinase-specific human recombinant TCRL antibodies (Adicet)tyrosinase-specific human recombinant TCRL antibodies (Applied Immune Technologies)tyrosinase-specific human recombinant T-Cell Receptor-Like antibodies (Applied Immune Technologies)

ClassificationBiologics > Protein drugs > Immunoglobulin > AntibodyBiologics > Protein drugs > Recombinant protein

Mechanisms of ActionHuman leukocyte antigen modulators

TargetsHuman leukocyte antigen

Therapy Area/IndicationsMelanoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryIsrael

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAdicet Bio Inc

China Registration ClassN/A

Develop Information

Active CompaniesAdicet Bio Inc

Inactive CompaniesN/A

Active IndicationsMelanoma

Inactive IndicationsN/A

Other Information

ATC CodeN/A